Epidemiology and etiology

Childhood Leukemias, Second Edition

Volumn , Issue , 2006, Pages 48-66

  Spector, Logan G ^a   Ross, Julie A ^a   Robison, Leslie L ^a   Bhatia, Smita ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649430365     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511471001.004     Document Type: Chapter

References (226)

1. Gurney, J. G., Severson, R. K., Davis, S., et al. Incidenceofcancer in children in the United States. Sex-, race-, and 1-year agespecific rates by histologic type. Cancer, 1995; 75: 2186-95.
2. Linet, M. S. & Devesa, S. S. Descriptive epidemiology of childhood leukaemia. Br J Cancer, 1991; 63: 424-9.
3. Glazer, E. R., Perkins, C. I., Young, J. L., Jr., et al. Cancer among Hispanic children in California, 1988-1994: comparison with non-Hispanic white children. Cancer, 1999; 86: 1070-9.
4. Douer, D., Preston-Martin, S., Chang, E., et al. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood, 1996; 87: 308-13.
5. Ferlay, J., Bray, F., Pisani, P., & Parkin, D. M. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. (Lyon, France: IARC Press, 2001).
6. Gurney, J. G., Davis, S., Severson, R. K., et al. Trends in cancer incidence among children in the U. S. Cancer, 1996; 78: 532-41.
7. Blair, V. & Birch, J. M. Patterns and temporal trends in the incidence of malignant disease in children: I. Leukaemia and lymphoma. Eur J Cancer, 1994; 30A: 1490-8.
8. McWhirter, W. R. & Petroeschevsky, A. L. Incidence trends in childhood cancer in Queensland, 1973-1988. Med J Aust, 1991; 154: 453-5.
9. Bunin, G. R., Feuer, E. J., Witman, P. A., & Meadows, A. T. Increasing incidence of childhood cancer: report of 20 years experience from the greater Delaware Valley Pediatric Tumor Registry. Paediatr Perinat Epidemiol, 1996; 10: 319-38.
10. Kaatsch, P., Haaf, G., &Michaelis, J. Childhood malignancies in Germany-methods and results of a nationwide registry. Eur J Cancer, 1995; 31A: 993-9.
11. Linet, M.S., Ries, L. A., Smith, M.A., Tarone, R. E., &Devesa, S. S. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst, 1999; 91: 1051-8.
12. Taylor, G. M. & Birch, J. M. The hereditary basis of human leukemia. In Henderson, E. S., Lister, T. A., & Greaves, M. F., eds., Leukemia (Philadelphia, PA: W. B. Saunders, 1996), pp. 210-45.
13. Norppa, H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ Health Perspect, 1997; 105(Suppl. 4): 829-35.
14. Spector, L. G., Xie, Y., Robison, L. L., et al. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev, 2005; 14: 651-5.
15. Puchkova, G. P., Prigogina, E. L., Fleischmann, E.W., Drosdova, T. S., &Mayakwa, S. A. Chromosome abnormalities in chronic myeloid leukemia in children. Hum Genet, 1983; 64: 257-62.
16. Woods, W. G., Nesbit, M. E., Buckley, J., et al. Correlation of chromosome abnormalities with patient characteristics, histologic subtype, and induction success in children with acute nonlymphocytic leukemia. J Clin Oncol, 1985; 3: 3-11.
17. Cimino, G., LoCoco, F., Biondi, A., et al. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. Blood, 1993; 82: 544-6.
18. Pui, C. H., Raimondi, S. C., Murphy, S. B., et al. An analysis of leukemic cell chromosomal features in infants. Blood, 1987; 69: 1289-93.
19. Stone, R.M.&Mayer, R. J., Theuniqueaspects of acute promyelocytic leukemia. J Clin Oncol, 1990; 8: 1913-21.
20. Secker-Walker, L. M., Berger, R., Fenaux, P., et al. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia, 1992; 6: 363-9.
21. Crist, W., Carroll, A., Shuster, J., et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood, 1990; 76: 489-94.
22. Shurtleff, S. A., Buijs, A., Behm, F. G., et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia, 1995; 9: 1985-9.
23. Robison, L. L. & Neglia, J. P. Epidemiology of Down syndrome and childhood acute leukemia. Prog Clin Biol Res, 1987; 246: 19-32.
24. Fong, C. T. & Brodeur, G. M. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics, and the mechanisms of leukemogenesis. Cancer Genet Cytogenet, 1987; 28: 55-76.
25. Zipursky, A., Thorner, P., De Harven, E., Christensen, H., & Doyle, J. Myelodysplasiaandacutemegakaryoblasticleukemia in Down's syndrome. Leuk Res, 1994; 18: 163-71.
26. Sacchi, N. Downsyndromeandchromosome21abnormalities in leukaemia. Baillieres Clin Haematol, 1992; 5: 815-31.
27. Mullvihill, J. J. Congenital and genetic diseases. In J. F. Fraumeni, Jr., ed., Persons at High Risk of Cancer (San Diego, CA: Academic Press, 1975), pp. 3-31.
28. Bader, J. L. & Miller, R. W. Neurofibromatosis and childhood leukemia. J Pediatr, 1978; 92: 925-9.
29. German, J., Bloom, D., & Passarge, E. Bloom's syndrome. VII. Progress report for 1978. Clin Genet, 1979; 15: 361-7.
30. Woods, W. G., Roloff, J. S., Lukens, J. N., & Krivit, W. The occurrence of leukemia in patients with the Shwachman syndrome. J Pediatr, 1981; 99: 425-8.
31. Hecht, F.&Hecht, B.K. Cancerin ataxia-telangiectasia patients. Cancer Genet Cytogenet, 1990; 46: 9-19.
32. Linet, M. The Leukemias: Epidemiological Aspects (New York: Oxford University Press, 1985).
33. Bloomfield, C. D. & Brunning, R. D. Acute leukemia as a terminal event in nonleukemic hematopoietic disorders. Semin Oncol, 1976; 3: 297-317.
34. Zeidler, C., Reiter, A., Yakisan, E., et al. Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia. Klin Padiatr, 1993; 205: 264-71.
35. Shannon, K. M., Turhan, A. G., Rogers, P. C., & Kan, Y. W. Evidence implicating heterozygous deletion of chromosome in the pathogenesis of ftreatial leukemia associated with monosomy 7. Genomics, 1992; 14: 121-5.
36. Narod, S. A., Stiller, C., & Lenoir, G. M. An estimate of the heritable fraction of childhood cancer. Br J Cancer, 1991; 63: 993-9.
37. Robison, L. L., Nesbit, M. E., Jr., Sather, H. N., et al. Down syndrome and acute leukemia in children: a 10-year retrospective survey from Children's Cancer Study Group. J Pediatr, 1984; 105: 235-42.
38. Watson, M. S., Carroll, A. J., Shuster, J. J., et al. Trisomy 21 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study (8602). Blood, 1993; 82: 3098-102.
39. Mertens, A. C., Wen, W., Davies, S. M., et al. Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr, 1998; 133: 617-23.
40. Narod, S. A., Hawkins, M. M., Robertson, C. M., & Stiller, C. A. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet, 1997; 60: 474-85.
41. Anderson, R. Familial leukemia. Am J Dis Child, 1951; 81: 313-322.
42. Maklin, M. Inheritance of cancer of the stomach and large intestine in man. J Natl Cancer Inst, 1960; 24: 551-571.
43. Gunz, F. W., Gunz, J. P., Vincent, P. C., et al. Thirteen cases of leukemia in a family. J Natl Cancer Inst, 1978; 60: 1243-50.
44. Farwell, J. & Flannery, J. T. Cancer in relatives of children with central-nervous-system neoplasms. N Engl J Med, 1984; 311: 749-53.
45. Mac Mahon, B. & Levy, M. A. Prenatal origin of leukemia: evidence from twins. NEngl J Med, 1964; 270: 1082-1085.
46. Keith, L., Brown, E. R., Ames, B., Stotsky, M., & Keith, D. M. Leukemia in twins: antenatal and postnatal factors. Acta Genet Med Gemellol, 1976; 25: 336-41.
47. Chaganti, R. S., Miller, D. R., Meyers, P. A., & German, J. Cytogenetic evidence of the intrauterine origin of acute leukemia in monozygotic twins. NEngl J Med, 1979; 300: 1032-4.
48. Hartley, S. E. & Sainsbury, C. Acute leukaemia and the same chromosome abnormality in monozygotic twins. Hum Genet, 1981; 58: 408-10.
49. Strong, L. C. Genetics, etiology, and epidemiology of childhood cancer. In W. W. Sutow, T. J. Vietti & D. J. Ferrbach, eds., Cambridge Books Online (c) Cambridge University Press, 2009 Epidemiology and etiology 61 Clinical Pediatric Oncology (St. Louis, MO: Mosby, 1984), pp. 14-41.
50. Elwood, P. C. Possible explanation of the high concordance for acute leukemia in monozygotic twins. Lancet, 1971; 1: 699.
51. Buckley, J.D., Buckley, C. M., Breslow, N. E., et al. Concordance for childhood cancer in twins. Med Pediatr Oncol, 1996; 26: 223-9.
52. Ford, A.M., Ridge, S. A., Cabrera, M.E., et al. Inuterorearrangements in the trithorax-related oncogene in infant leukaemias. Nature, 1993; 363: 358-60.
53. Maia, A. T., Ford, A. M., Jalali, G. R., et al. Molecular tracking of leukemogenesis in a triplet pregnancy. Blood, 2001; 98: 478-82.
54. Ford, A. M., Pombo-de-Oliveira, M. S., McCarthy, K. P., et al. Monoclonal origin of concordant T-cell malignancy in identical twins. Blood, 1997; 89: 281-5.
55. Ford, A. M., Bennett, C. A., Price, C. M., et al. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci U S A, 1998; 95: 4584-8.
56. Hawkins, M. M., Draper, G. J., &Winter, D. L. Cancer in the offspring of survivors of childhood leukaemia and non-Hodgkin lymphomas. Br J Cancer, 1995; 71: 1335-9.
57. Bajnoczky, K., Khezri, S., Kajtar, P., et al. Nochromosomalinstability in offspring of survivors of childhood malignancy. Cancer Genet Cytogenet, 1999; 109: 79-80.
58. Perrillat, F., Clavel, J., Jaussent, I., et al. Family cancer history and risk of childhood acute leukemia (France). Cancer Causes Control, 2001; 12: 935-41.
59. Grenwald. Benzene and leukemia. Crit Rev Toxicol, 2002; 32: 155-210.
60. Stewart, A. Asurvey of childhood malignancies. Br Med J, 1958; 2: 1495-507.
61. Mac Mahon, B. & Newill, V. A. Birth characteristics of children dying of malignant neoplasms. J Natl Cancer Inst, 1962; 28: 231-44.
62. Gibson, R. W., Bross, I. D. J., Graham, S., et al. Leukemia in children exposed to multiple risk factors. N Engl J Med, 1968; 279: 906-9.
63. Stewart, A. & Kneale, G. W. Radiation dose effects in relation to obstetric x-rays and childhood cancers. Lancet, 1970; 1: 1185-8.
64. Savitz, D. A., Wachtel, H., Barnes, F. A., John, E. M., & Tvrdik, J. G. Case-control study of childhood cancer and exposure to 60-Hz magnetic fields. Am J Epidemiol, 1988; 128: 21-38.
65. London, S. J., Thomas, D. C., Bowman, J. D., et al. Exposure to residential electric and magnetic fields and risk of childhood leukemia. Am J Epidemiol, 1991; 134: 923-37.
66. Linet, M. S., Hatch, E. E., Kleinerman, R. A., et al. Residential exposure to magnetic fieldsandacute lymphoblastic leukemia in children. NEngl J Med, 1997; 337: 1-7.
67. Preston, D. L., Kusumi, S., Tomonaga, M., et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res, 1994; 137(2 Suppl.): S68-97.
68. Doll, R. Hazardsof ionising radiation:100years of observations on man. Br J Cancer, 1995; 72: 1339-49.
69. Harvey, E. B., Boice, J. D., Jr., Honeyman, M., & Flannery, J. T. Prenatal x-ray exposure and childhood cancer in twins. NEngl J Med, 1985; 312: 541-5.
70. Rodvall, Y., Pershagen, G., Hrubec, Z., et al. PrenatalX-rayexposureandchildhood cancer in Swedish twins. Int J Cancer, 1990; 46: 362-5.
71. Mole, R. H. Childhood cancer after prenatal exposure to diagnostic X-ray examinations in Britain. Br J Cancer, 1990; 62: 152-68.
72. Boice, J. D. & Inskip, P. D. Radiation-induced leukemia. In E. S. Henderson, T. A. Lister, & M. F. Greaves, eds., Leukemia (Philadelphia, PA:W. B. Saunders, 1996), pp. 195-209.
73. Darby, S. C.&Weiss, H.A. Humanstudies in radiationleukemogenesis. In J. H. Hendry & B. I. Lord, eds., Radiation Toxicology: Bone Marrow and Leukemia (London: Taylor & Francis, 1995), pp. 337-53.
74. Doll, R. & Wakeford, R. Risk of childhood cancer from fetal irradiation. Br J Radiol, 1997; 70: 130-9.
75. Simpson, C. I., Hempelmann, L. H., & Fuller, L. M. Neoplasms in children treated with x-rays in infancy for thymic enlargement. Radiology, 1955; 64: 840-55.
76. Ron, E. & Modon, B. Thyroid and other neoplasms following childhood scalp irradiation. In J. D. Boice & J. F. Fraumeni, eds., Radiation Carcinogenesis, Epidemiology and Biological Significance (New York: Raven Press, 1984), pp. 139-51.
77. Tucker, M. A., Coleman, C. N., Cox, R. S., Varghese, A. & Rosenberg, S. A. Risk of second cancers after treatment for Hodgkin's disease. NEngl J Med, 1988; 318: 76-81.
78. Egeler, R. M., Neglia, J. P., Arico, M., et al. Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol, 1994; 23: 81-5.
79. Infante-Rivard, C., Mathonnet, G., & Sinnett, D. Risk of childhood leukemia associated with diagnostic irradiation and polymorphisms in DNA repair genes. Environ Health Perspect, 2000; 108: 495-8.
80. Linos, A., Kyle, R. A., Elveback, L. R., & Kurland, L. T. Leukemia in Olmsted County, Minnesota, 1965-1974. Mayo Clin Proc, 1978; 53: 714-18.
81. Boice, J. D., Jr. The danger of X-rays-real or apparent?NEngl J Med, 1986; 315: 828-30.
82. Hjalmars, U., Kulldorff, M., &Gustafsson, G. Riskofacutechildhood leukaemia in Sweden after the Chernobyl reactor accident. Swedish Child Leukaemia Group. BMJ, 1994; 309: 154-7.
83. Auvinen, A., Hakama, M., Arvela, H., et al. Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976-92. BMJ, 1994; 309: 151-4.
84. Cartwright, R. A., McKinney, P. A., Alexander, F. E., & Ricketts, J. Leukemia in young children. Lancet, 1988; 2: 960.
85. Gibson, B. E., Eden, O. B., Barrett, A., Stiller, C. A., & Draper, G. J. Leukaemia in young children in Scotland. Lancet, 1988; 2: 630.
86. Michaelis, J., Kaletsch, U., Burkart, W., & Grosche, B. Infant leukaemia after the Chernobyl accident. Nature, 1997; 387: 246.
87. Petridou, E., Proukakis, C., Tong, D., et al. Trends and geographical distribution of childhood leukemia in Greece in relation to the Chernobyl accident. Scand J Soc Med, 1994; 22: 127-31.
88. Petridou, E., Trichopoulos, D., Dessypris, N., et al. Infant leukaemiaafter in uteroexposure to radiation from Chernobyl. Nature, 1996; 382: 352-3.
89. Parkin, D. M., Cardis, E., Masuyer, E., et al. Childhood leukemia following the Chernobyl accident: the European Childhood Leukemia-Lymphoma Incidence Study (ECLIS). Eur J Cancer, 1992; 29A: 87-95.
90. Ivanov, E. P., Tolochoko, G., Lazarev, V. S. & Shuvaeva, L. Child leukaemia after Chernobyl. Nature, 1993; 365: 702.
91. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources and Effects of Ionizing Radiation. New York: United Nations, 1994.
92. Stevens, W., Thomas, D. C., Lyon, J. L., et al. Leukemia in Utah andradioactivefallout fromthe Nevadatest site.Acase-control study. JAMA, 1990; 264: 585-91.
93. Cook-Mozaffari, P. J., Darby, S. C., Doll, R., et al. Geographical variation in mortality fromleukaemia and other cancers in England and Wales in relation to proximity to nuclear installations, 1969-78. Br J Cancer, 1989; 59: 476-85.
94. Bithell, J. F., Dutton, S. J., Draper, G. J., &Neary, N. M. Distribution of childhood leukaemias and non-Hodgkin's lymphomas near nuclear installations in England and Wales. BMJ, 1994; 309: 501-5.
95. Hill, C. & Laplanche, A. Overall mortality and cancer mortality around French nuclear sites. Nature, 1990; 347: 755-7.
96. Jablon, S., Hrubec, Z. & Boice, J. D., Jr. Cancer in populations living near nuclear facilities. A survey of mortality nationwide and incidence in two states. JAMA, 1991; 265: 1403-8.
97. Jablon, S., Hrubec, Z. & Boice, J. D., Jr. Cancer in Populations Living Near Nuclear Facilities. NIH Publication 90-874). (Bethesda, MD: Public Health Service, Department of Health and Human Services, 1990).
98. Michaelis, J., Keller, B., Haaf, G., & Kaatsch, P. Incidence of childhood malignancies in the vicinity ofwest Germannuclear power plants. Cancer Causes Control, 1992; 3: 255-63.
99. Clarke, E. A., McLaughlin, J., & Anderson, T. W. Childhood Leukaemia Around Canadian Nuclear Facilities:Phase II. Final Report. (Ottawa, Canada: Atomic Energy Control Board, 1991).
100. Committee of Medical Aspects of Radiation in the Environment (COMARE). The Incidence of Cancer and Leukaemia in Young People in the Vicinity of the Sellafield Site, West Cumbria: Further Studies and an Update of the Situation Since the Publication of the Report of the Black Advisory Group in 1984. (London: Her Majesty's Stationery Office, 1996).
101. Gardner, M. J. Father's occupational exposure to radiation and the raised level of childhood leukemia near the Sellafield nuclear plant. Environ Health Perspect, 1991; 94: 5-7.
102. Shu, X. O., Reaman, G. H., Lampkin, B., et al. Association of paternal diagnostic X-ray exposure with risk of infant leukemia. Investigators of the Children's Cancer Group. Cancer Epidemiol Biomarkers Prev, 1994; 3: 645-53.
103. McLaughlin, J. R., Clarke, E. A., Nishri, E. D., & Anderson, T. W. Childhood leukemia in the vicinity of Canadian nuclear facilities. Cancer Causes Control, 1993; 4: 51-8.
104. Parker, L., Craft, A.W., Smith, J., et al. Geographical distribution of preconceptional radiation doses to fathers employed at the Sellafield nuclear installation, West Cumbria. BMJ, 1993; 307: 966-71.
105. Henshaw, D. L., Eatough, J. P., & Richardson, R. B. Radon as a causative factor in induction of myeloid leukaemia and other cancers. Lancet, 1990; 335: 1008-12.
106. Alexander, F. E., McKinney, P. A., &Cartwright, R. A. Radon and leukaemia. Lancet, 1990; 335: 1336-7.
107. Lubin, J. H., Linet, M. S., Boice, J. D. Jr., et al. Case-control study of childhood acute lymphoblastic leukemia and residential radon exposure. J Natl Cancer Inst, 1998; 90: 294-300.
108. Steinbuch, M., Weinberg, C. R., Buckley, J. D., Robison, L. L., & Sandler, D. P. Indoor residential radon exposure and risk of childhood acute myeloid leukaemia. Br J Cancer, 1999; 81: 900-6.
109. Kaletsch, U., Kaatsch, P., Meinert, R., et al. Childhood cancer and residential radon exposure-results of a population-based case-control study in Lower Saxony (Germany). Radiat Environ Biophys, 1999; 38: 211-5.
110. UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 1: radon gas. Br J Cancer, 2002; 86: 1721-6.
111. Axelson, O., Fredrikson, M., Akerblom, G., & Hardell, L. Leukemia in childhood and adolescence and exposure to ionizing radiation in homes built from uranium-containing alum shale concrete. Epidemiology, 2002; 13: 146-50.
112. Watts, G. Power to confuse. BMJ, 2005; 330: 1293.
113. McBride, M. L., Gallagher, R. P., Theirault, G., et al. Powerfrequency electric and magnetic fields and risk of childhood leukemia in Canada. Am J Epidemiol, 1999; 149: 831-42.
114. Anonymous. Exposure to power-frequency magnetic fields and the risk of childhood cancer. UK Childhood Cancer Study Investigators. Lancet, 1999; 354: 1925-31.
115. Soderberg, K. C., Naumburg, E., Anger, G., et al. Childhood leukemia and magnetic fields in infant incubators. Epidemiology, 2002; 13: 45-9.
116. Ahlbom, A., Day, N., Feychting, M., et al. A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer, 2000; 83: 692-8.
117. Greenland, S., Sheppard, A. R., Kaune, W. T., Poole, C., & Kelsh, M. A. A pooled analysis of magnetic fields, wire codes, and childhood leukemia. Childhood Leukemia-EMF Study Group. Epidemiology, 2000; 11: 624-34.
118. Lowengart, R. A., Peters, J. M., Cicioni, C., et al. Childhood leukemia and parents' occupational and home exposures. J Natl Cancer Inst, 1987; 79: 39-46.
119. Shu, X. O., Gao, Y. T., Brinton, L. A., et al. A population-based case-control study ofchildhoodleukemia in Shanghai. Cancer, 1988; 62: 635-44.
120. Buckley, J.D., Robison, L. L., Swotinsky, R., et al. Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Children's Cancer Study Group. Cancer Res, 1989; 49: 4030-7.
121. Leiss, J. K. & Savitz, D. A. Home pesticide use and childhood cancer: a case-control study. Am J Public Health, 1995; 85: 249-52.
122. Zahm, S.H. Childhoodleukemiaandpesticides. Epidemiology, 1999; 10: 473-5.
123. Daniels, J. L., Olshan, A. F., & Savitz, D. A. Pesticides and childhood cancers. Environ Health Perspect, 1997; 105: 1068-77.
124. Shu, X. O., Stewart, P., Wen, W. Q., et al. Parental occupational exposure to hydrocarbons and risk of acute lymphocyticleukemiain offspring. Cancer Epidemiol Biomarkers Prev, 1999; 8: 783-91.
125. Steensel-Moll, H. A. van, Valkenburg, H. A., Vandenbroucke, J. P., & Zanen, G. E. van. Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol, 1985; 14: 555-9.
126. Gold, E. B., Diener, M. D., & Szklo, M. Parental occupations and cancer in children-a case-control study and review of the methodologic issues. J Occup Med, 1982; 24: 578-84.
127. McKinney, P. A., Roberts, B. E., O'Brien, C., et al. Chronic myeloid leukaemia in Yorkshire: a case control study. Acta Haematol, 1990; 83: 35-8.
128. Shaw, G., Lavey, R., Jackson, R., & Austin, D. Association of childhood leukemia with maternal age, birth order, and paternal occupation. A case-control study. Am J Epidemiol, 1984; 119: 788-95.
129. Infante-Rivard, C., Mur, P., Armstrong, B., Alvarez-Dardet, C., & Boulmar, F. Acute lymphoblastic leukaemia among Spanish children and mothers' occupation: a case-control study. J Epidemiol Community Health, 1991; 45: 11-5.
130. Schuz, J., Kaletsch, U., Meinert, R., Kaatsch, P., & Michaelis, J. Risk of childhood leukemia and parental self-reported occupational exposure to chemicals, dusts, and fumes: results from pooled analyses of German population-based case-control studies. Cancer Epidemiol Biomarkers Prev, 2000; 9: 835-8.
131. Lyons, R. A., Monaghen, S. P., Heaven, M., et al. Incidence of leukaemia and lymphoma in young people in the vicinity of the petrochemical plant at Baglan Bay, South Wales, 1974 to 1991. Occup Environ Med, 1995; 52: 225-8.
132. Sans, S., Elliott, P., Kleinschmidt, I., et al. Cancer incidence andmortality near the BaglanBay petrochemical works, South Wales. Occup Environ Med, 1995; 52: 217-24.
133. Freedman, D. M., Stewart, P., Kleinerman, R. A., et al. Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health, 2001; 91: 564-7.
134. Pearson, R. L., Wachtel, H., &Ebi, K. L. Distance-weighted traffic density in proximity to a home is a risk factor for leukemia and other childhood cancers. J Air Waste Manag Assoc, 2000; 50: 175-80.
135. Reynolds, P., Elkin, E., Scalf, R., Von Behren, J., & Neutra, R. R. A case-control pilot study of traffic exposures and early childhood leukemia using a geographic information system. Bioelectromagnetics, 2001; Suppl. 5: S58-68.
136. Reynolds, P., Von Behren, J., Gunier, R. B., et al. Traffic patterns and childhood cancer incidence rates in California, United States. Cancer Causes Control, 2002; 13: 665-73.
137. Alexander, F., Cartwright, R., McKinney, P. A., & Ricketts, T. J. Investigation of spacial clustering of rare diseases: childhood malignancies in North Humberside. J Epidemiol Community Health, 1990; 44: 39-46.
138. Wulff, M., Hogberg, U., & Sandstrom, A. Cancer incidence for children born in a smelting community. Acta Oncol, 1996; 35: 179-83.
139. Feychting, M., Plato, N., Nise, G., & Ahlbom, A. Paternal occupational exposures and childhood cancer. Environ Health Perspect, 2001; 109: 193-6.
140. Robison, L. L., Buckley, J. D., Daigle, A. E., et al. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report fromthe Children's Cancer Study Group). Cancer, 1989; 63: 1904-11.
141. Sarasua, S. & Savitz, D. A. Cured and broiled meat consumption in relation to childhood cancer:Denver, Colorado (United States). Cancer Causes Control, 1994; 5: 141-8.
142. Thompson, J. R., Gerald, P. F., Willoughby, M. L., & Armstrong, B. K. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet, 2001; 358: 1935-40.
143. Peters, J. M., Preston-Martin, S., London, S. J., et al. Processed meatsandrisk ofchildhoodleukemia(California, USA). Cancer Causes Control, 1994; 5: 195-202.
144. Buckley, J. D., Buckley, C. M., Ruccione, K., et al. Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Children's Cancer Group. Leukemia, 1994; 8: 856-64.
145. Severson, R. K., Buckley, J. D., Woods, W. G., Benjamin, D., & Robison, L. L. Cigarette smoking and alcohol consumption by parents of children with acute myeloid leukemia: an analysis within morphological subgroups-a report from the Children's Cancer Group. Cancer Epidemiol Biomarkers Prev, 1993; 2: 433-9.
146. Duijn, C. M. van, Steensel-Moll, H. A. van, Coebergh, J. W., & Zanen, G. E. van. Risk factors for childhood acute nonlymphocytic leukemia: an association with maternal alcohol consumption during pregnancy? Cancer Epidemiol Biomarkers Prev, 1994; 3: 457-60.
147. Shu, X. O., Ross, J. A., Pendergrass, T.W., et al. Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Children's Cancer Group study. J Natl Cancer Inst, 1996; 88: 24-31.
148. Sorahan, T., Lancashire, R., Prior, P., Peck, I., &Stewart, A. Childhood cancer and parental use of alcohol and tobacco. Ann Epidemiol, 1995; 5: 354-9.
149. Stjernfeldt, M., Berglund, K., Lindsten, J., & Ludvigsson, J. Maternal smoking and irradiation during pregnancy as risk factors for child leukemia. Cancer Detect Prev, 1992; 16: 129-35.
150. Mucci, L. A., Granath, F., & Cnattingius, S. Maternal smoking and childhood leukemia and lymphoma risk among 1, 440, 542 Swedish children. Cancer Epidemiol Biomarkers Prev, 2004;13: 1528-33.
151. John, E. M., Savitz, D. A., & Sandler, D. P. Prenatal exposure to parents' smokingandchildhood cancer. Am J Epidemiol, 1991; 133: 123-32.
152. Buckley, J.D., Hobbie, W. L., Ruccione, K., et al. Maternal smokingduringpregnancyandtherisk ofchildhoodcancer[letter]. Lancet, 1986; 2: 519-20.
153. Pershagen, G., Ericson, A., & Otterblad-Olausson, P. Maternal smoking in pregnancy: does it increase the risk of childhood cancer? Int J Epidemiol, 1992; 21: 1-5.
154. McKinney, P. A. & Stiller, C. Maternal smoking during pregnancy and the risk of childhood leukaemia. Lancet, 1986; 2: 519.
155. Li, F. P. Maternal smoking during pregnancy and the risk of childhood cancer. Lancet, 1986; 2: 520.
156. Ji, B. T., Shu, X.O., Linet, M. S., et al. Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst, 1997; 89: 238-44.
157. Sorahan, T., Lancashire, R. J., Hulten, M. A., Peck, I., & Stewart, A. M. Childhood cancer and parental use of tobacco: deaths from 1953 to 1955. Br J Cancer, 1997; 75: 134-8.
158. Brondum, J., Shu, X. O., Steinbuch, M., et al. Parental cigarette smoking and the risk of acute leukemia in children. Cancer, 1999; 85: 1380-8.
159. Sandler, D. P., Wilcox, A. J., & Everson, R. B. Cumulative effects of lifetime passive smoking on cancer risk. Lancet, 1985; 1: 312-5.
160. Kaye, S. A., Robison, L. L., Smithson, W. A., et al. Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer, 1991; 68: 1351-5.
161. Yeazel, M. W., Buckley, J. D., Woods, W. G., Ruccione, K., & Robison, L. L. History of maternal fetal loss and increased risk of childhood acute leukemia at an early age. A report from the Children's Cancer Group. Cancer, 1995; 75: 1718-27.
162. Gibson, R.W., Bross, I.D. J., &Graham, S. Leukemia in children exposed to multiple risk factors. NEngl J Med, 1968;279: 906-9.
163. Ross, J. A., Potter, J.D., Shu, X.O., et al. Evaluating the relationships among maternal reproductive history, birth characteristics, and infant leukemia: a report from the Children's Cancer Group. Ann Epidemiol, 1997; 7: 172-9.
164. Westergaard, T., Andersen, P. K., Pedersen, J.B., et al. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst, 1997; 89: 939-47.
165. Hemminki, K., Kyyronen, P., &Vaittinen, P. Parental age as a risk factor of childhood leukemia and brain cancer in offspring. Epidemiology, 1999; 10: 271-5.
166. Dockerty, J. D., Draper, G., Vincent, T., Rowan, S. D., & Bunch, K. J. Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. Int J Epidemiol, 2001; 30: 1428-37.
167. Zack, M., Adami, H. O., & Ericson, A. Maternal and perinatal risk factors for childhood leukemia. Cancer Res, 1991; 51: 3696-701.
168. Hjalgrim, L. L., Rostgaard, K., Hjalgrim, H., et al. Birth weight andrisk for childhood leukemia in Denmark, Sweden, Norway, and Iceland. J Natl Cancer Inst, 2004; 96: 1549-56
169. Petridou, E., Skalkidou, A., Dessypris, N., et al. Endogenousrisk factors for childhood leukemia in relation to the IGF system (Greece). The Childhood Haematologists-Oncologists Group. Cancer Causes Control, 2000; 11: 765-71.
170. Lei, U., Wohlfahrt, J., Hjalgrim, H., et al. Neonatal level of thyroid-stimulating hormone and acute childhood leukemia. Int J Cancer, 2000; 88: 486-8.
171. Gale, K. B., Ford, A. M., Repp, R., et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A, 1997; 94: 13 950-4.
172. Pui, C. H., Ribeiro, R. C., Hancock, M. L., et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med, 1991; 325: 1682-7.
173. Broeker, P. L., Super, H. G., Thirman, M. J., et al. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood, 1996; 87: 1912-22.
174. Wang, J. C.DNAtopoisomerases. Annu Rev Biochem, 1996; 65: 635-92.
175. Ross, J. A., Potter, J. D., Reaman, G. H., Pendergrass, T. W., & Robison, L. L. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control, 1996; 7: 581-90.
176. Ross, J. A. Maternal diet and infant leukemia: a role for DNA topoisomerase II inhibitors? Int J Cancer Suppl, 1998; 11: 26-8.
177. Strick, R., Strissel, P. L., Borgers, S., Smith, S. L., & Rowley, J. D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci U S A, 2000; 97: 4790-5.
178. Alexander, F. E., Patheal, S. L., Biondi, A., et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res, 2001; 61: 2542-6.
179. Ross, J. A., Potter, J. D., & Robison, L. L. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst, 1994; 86: 1678-80.
180. Greave, M. F. Infant leukaemia biology, aetiology and treatment. Leukemia, 1996; 10: 372-7.
181. Kinlen, L. J. Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer, 1995; 71: 1-5.
182. Anderson, R. M. &May, R. M. Immunisation and herd immunity. Lancet, 1990; 335: 641-5.
183. Boutou, O., Guizard, A. V., Slama, R., Pottier, D., & Spira, A. Population mixing and leukaemia in young people around the La Hague nuclear waste reprocessing plant. Br J Cancer, 2002; 87: 740-5.
184. Langford, I. Childhood leukaemia mortality and population change in England and Wales 1969-73. Soc Sci Med, 1991; 33: 435-40.
185. Stiller, C. A. & Boyle, P. J. Effect of population mixing and socioeconomic status in England and Wales, 1979-85, on lymphoblastic leukaemia in children. BMJ, 1996; 313: 1297-300.
186. Dickinson, H. O. & Parker, L. Quantifying the effect of population mixing on childhood leukaemia risk: the Seascale cluster. Br J Cancer, 1999; 81: 144-51.
187. Koushik, A., King, W. D., &McLaughlin, J. R. An ecologic study of childhood leukemia and population mixing in Ontario, Canada. Cancer Causes Control, 2001; 12: 483-90.
188. Dickinson, H.O., Hammal, D. M., Bithell, J. F., &Parker, L. Population mixing and childhood leukaemia and non-Hodgkin's lymphoma in census wards in England and Wales, 1966-87. Br J Cancer, 2002; 86: 1411-3.
189. Parslow, R. C., Law, G. R., Feltbower, R., Kinsey, S. E., & McKinney, P. A. Population mixing, childhood leukaemia, CNS tumours and other childhood cancers in Yorkshire. Eur J Cancer, 2002; 38: 2033-40.
190. Baccate, E.M. Social patterns of antibody to poliovirus. Lancet, 1983; 1: 778-83.
191. Dworsky, M., Yow, M., Stagno, S., Pass, R. F., & Alford, C. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics, 1983; 72: 295-9.
192. Parker, L. Breast-feeding and cancer prevention. Eur J Cancer, 2001; 37: 155-8.
193. Ma, X., Buffler, P. A., Selvin, S., et al. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer, 2002; 86: 1419-24.
194. Perrillat, F., Clavel, J., Auclerc, M. F., et al. Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer, 2002; 86: 1064-9.
195. Gilham, C., Peto, J., Simpson, J. et at. Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-contol study. BMJ, 2005; 330: 1294.
196. Rosenbaum, P. F., Buck, G. M., &Brecher, M. L. Early child-care and preschool experiences and the risk of childhood acute lymphoblastic leukemia. Am J Epidemiol, 2000; 152: 1136-44.
197. Neglia, J. P., Linet, M. S., Shu, X. O., et al. Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br J Cancer, 2000; 82: 234-40.
198. Gahrton, G., Wahren, B., Killander, D., & Foley, G. E. Epstein-Barr and other herpes virus antibodies in children with acute leukemia. Int J Cancer, 1971; 8: 242-9.
199. Groves, F. D., Sinha, D., Kayhty, H., Goedert, J. J., & Levine, P. H. Haemophilus influenzae type b serology in childhood leukaemia: a case-control study. Br J Cancer, 2001; 85: 337-40.
200. Heegaard, E. D., Jensen, L., Hornsleth, A., & Schmiegelow, K. The role of parvovirus B19 infection in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol, 1999; 16: 329-34.
201. Mac Kenzie, J., Gallagher, A., Clayton, R. A., et al. Screening for herpesvirus genomes in common acute lymphoblastic leukemia. Leukemia, 2001; 15: 415-21.
202. Mac Kenzie, J., Perry, J., Ford, A. M., Jarrett, R. F., & Greaves, M. JC and BK virus sequences are not detectable in leukaemic samples from children with common acute lymphoblastic leukaemia. Br J Cancer, 1999; 81: 898-9.
203. Salonen, M. J., Siimes, M. A., Salonen, E. M., Vaheri, A., & Koskiniemi, M. Antibody status to HHV-6 in children with leukaemia. Leukemia, 2002; 16: 716-9.
204. Dockerty, J. D., Skegg, D. C., Elwood, J. M., et al. Infections, vaccinations, and the risk of childhood leukaemia. Br J Cancer, 1999; 80: 1483-9.
205. McKinney, P. A., Juszczak, E., Findlay, E., Smith, K., &Thomson, C. S. Pre-and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study. Br J Cancer, 1999; 80: 1844-51.
206. Schuz, J., Kaatsch, P., Kaletsch, U., Meinert, R., & Michaelis, J. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol, 1999; 28: 631-9.
207. McKinney, P. A., Cartwright, R. A., Saiu, J. M., et al. The interregional epidemiological study of childhood cancer (IRESCC): a case control study of aetiological factors in leukaemia and lymphoma. Arch Dis Child, 1987; 62: 279-87.
208. Naumburg, E., Bellocco, R., Cnattingius, S., Jonzon, A., & Ekbom, A. Perinatal exposure to infection and risk of childhood leukemia. Med Pediatr Oncol, 2002; 38: 391-7.
209. Chan, L. C., Lam, T. H., Li, C. K., et al. Is the timing of exposure to infection a major determinant of acute lymphoblastic leukaemia in Hong Kong? Paediatr Perinat Epidemiol, 2002; 16: 154-65.
210. Greaves, M. F.&Alexander, F. E. An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia, 1993; 7: 349-60.
211. Taylor, G. M. & Birch, J. M. The hereditary basis of human leukemia. In E. S. Henderson, T. A. Lister, & M. F. Greaves, eds., Leukemia (Philadelphia, PA:W. B. Saunders, 1996), pp. 210-45.
212. Petridou, E., Kassimos, D., Kalmanti, M., et al. Age of exposure to infections and risk of childhood leukaemia. BMJ, 1993; 307: 774.
213. Tasaka, T., Lee, S., Spira, S., et al. Microsatellite instability duringtheprogressionofacutemyelocyticleukaemia. Br J Haematol, 1997; 98: 219-21.
214. Takeuchi, S., Seriu, T., Tasaka, T., et al. Microsatellite instability and other molecular abnormalities in childhood acute lymphoblastic leukaemia. Br J Haematol, 1997; 98: 134-9.
215. Baccichet, A., Benachenhou, N., Couture, F., Leclerc, J. M., & Sinnett, D. Microsatellite instability in childhood T cell acute lymphoblastic leukemia. Leukemia, 1997; 11: 797-802.
216. Finette, B. A., Poseno, T., & Albertini, R. J. V(D)J recombinasemediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res, 1996; 56: 1405-12.
217. Dorak, M. T., Lawson, T., Machulla, H. K., et al. Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia. Blood, 1999; 94: 694-700.
218. Taylor, G. M., Robinson, M.D., Binchy, A., et al. Preliminary evidence of an association between HLA-DPB1*0201 and childhood common acute lymphoblastic leukaemia supports an infectious aetiology. Leukemia, 1995; 9: 440-3.
219. Rothman, N., Wacholder, S., Caporaso, N. E., et al. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta, 2001; 1471: C1-10.
220. Nakachi, K., Imai, K., Hayashi, S., &Kawajiri, K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res, 1993; 53: 2994-9.
221. Hirvonen, A., Nylund, L., Kociba, P., Husgafvel-Pursiainen, K., &Vainio, H. Modulation of urinary mutagenicityby genetically determined carcinogen metabolism in smokers. Carcinogenesis, 1994; 15: 813-5.
222. Chen, H., Sandler, D. P., Taylor, J. A., et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet, 1996; 347: 295-7.
223. Davies, S. M., Robison, L. L., Buckley, J. D., et al. Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group study. Cancer Epidemiol Biomarkers Prev, 2000; 9: 563-6.
224. Chen, C. L., Liu, O., Pui, C. H., et al. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood, 1997; 89: 1701-7.
225. Davies, S. M., Bhatia, S., Ross, J. A., et al. Glutathione Stransferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood, 2002; 100: 67-71.
226. Blumer, J. L., Dunn, R., Esterhay, M. D., Yamashita, T. S., & Gross, S. Lymphocyte aromatic hydrocarbon responsiveness in acute leukemia of childhood. Blood, 1981; 58: 1081-8.